Related Experiment Video
Updated: Jun 15, 2025

Expression, Purification, and Antimicrobial Activity of S100A12
Published on: May 13, 2017
S100a8/A9 proteins: critical regulators of inflammation in cardiovascular diseases
Yu Sun1, Han Xu2, Weihan Gao2
1College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Insights
Neutrophil hyperexpression indicates inflammation and cardiovascular disease risk. S100 calcium binding protein A8/A9 (S100A8/A9) shows promise as a biomarker and therapeutic target for these conditions.
Area of Science:
- Cardiovascular Medicine
- Inflammation Biology
- Biomarker Discovery
Background:
- Neutrophil activation and hyperexpression are critical in inflammatory processes.
- This heightened neutrophil activity is linked to the development of various cardiovascular disorders.
- S100 calcium binding protein A8/A9 (S100A8/A9), originating from neutrophils, is emerging as a significant indicator for cardiovascular disease.
Purpose of the Study:
- To evaluate the potential of S100A8/A9 as a diagnostic biomarker for cardiovascular diseases.
- To assess S100A8/A9 as a therapeutic target for cardiovascular conditions.
- To analyze the structural and biological characteristics of S100A8/A9 in relation to cardiovascular health.
Main Methods:
- Review of existing literature on S100A8/A9.
- Analysis of S100A8/A9's role in atherosclerosis.
- Investigation of S100A8/A9's impact on myocardial infarction and ischemia/reperfusion injury.
- Assessment of S100A8/A9's involvement in heart failure.
Main Results:
- S100A8/A9 exhibits significant potential as a biomarker for cardiovascular disease diagnosis.
- The protein's biological properties suggest its utility as a therapeutic target.
- S100A8/A9 influences key cardiovascular conditions, including atherosclerosis, myocardial infarction, and heart failure.
Conclusions:
- S100A8/A9 is a promising biomarker for diagnosing cardiovascular diseases.
- Targeting S100A8/A9 may offer novel therapeutic strategies for cardiovascular conditions.
- Understanding S100A8/A9's role is crucial for managing inflammation-related cardiovascular disorders.
Abstract:
Neutrophil hyperexpression is recognized as a key prognostic factor for inflammation and is closely related to the emergence of a wide range of cardiovascular disorders. In recent years, S100 calcium binding protein A8/A9 (S100A8/A9) derived from neutrophils has attracted increasing attention as an important warning protein for cardiovascular disease. This article evaluates the utility of S100A8/A9 protein as a biomarker and therapeutic target for diagnosing cardiovascular diseases, considering its structural features, fundamental biological properties, and its multifaceted influence on cardiovascular conditions including atherosclerosis, myocardial infarction, myocardial ischemia/reperfusion injury, and heart failure.
Related Concept Videos
Inflammation
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Regulation of Angiogenesis and Blood Supply
Anticoagulant Drugs: Low-Molecular-Weight Heparins

